| Primary |
| Embolism |
40.5% |
| Thrombosis Prophylaxis |
39.7% |
| Hypertension |
6.3% |
| Atrial Fibrillation |
2.1% |
| Embolism Arterial |
1.7% |
| Cardiac Failure |
1.1% |
| Pain |
1.0% |
| Antacid Therapy |
0.8% |
| Antiplatelet Therapy |
0.8% |
| Vitamin Supplementation |
0.8% |
| Cardiac Disorder |
0.7% |
| Coronary Artery Disease |
0.7% |
| Diabetes Mellitus |
0.7% |
| Eczema |
0.6% |
| Acute Coronary Syndrome |
0.4% |
| Chemotherapy |
0.4% |
| Constipation |
0.4% |
| Dyslipidaemia |
0.4% |
| Heart Rate |
0.4% |
| Sjogren's Syndrome |
0.4% |
|
| Pneumonia |
13.3% |
| Ischaemic Stroke |
11.1% |
| Upper Gastrointestinal Haemorrhage |
7.8% |
| Aortic Aneurysm Rupture |
6.7% |
| Haematuria |
6.7% |
| Cerebral Infarction |
5.6% |
| Haemoglobin Decreased |
5.6% |
| Mesenteric Artery Embolism |
4.4% |
| Sepsis |
4.4% |
| Urinary Tract Infection |
4.4% |
| Death |
3.3% |
| Gilbert's Syndrome |
3.3% |
| Large Intestinal Haemorrhage |
3.3% |
| Pancreatic Carcinoma |
3.3% |
| Psoriasis |
3.3% |
| Transient Ischaemic Attack |
3.3% |
| Viral Infection |
3.3% |
| Abdominal Wall Haematoma |
2.2% |
| Arthralgia |
2.2% |
| Carotid Artery Stenosis |
2.2% |
|
| Secondary |
| Thrombosis Prophylaxis |
46.3% |
| Product Used For Unknown Indication |
20.5% |
| Embolism |
9.3% |
| Drug Use For Unknown Indication |
4.2% |
| Atrial Fibrillation |
4.0% |
| Depression |
1.9% |
| Embolism Arterial |
1.7% |
| Cerebrovascular Accident Prophylaxis |
1.6% |
| Anticoagulant Therapy |
1.5% |
| Pain |
1.2% |
| Diabetes Mellitus |
1.1% |
| Arrhythmia Prophylaxis |
1.0% |
| Diuretic Therapy |
1.0% |
| Cardiac Disorder |
0.9% |
| Pain In Extremity |
0.9% |
| Convulsion |
0.6% |
| Gout |
0.6% |
| Anxiety |
0.5% |
| Back Pain |
0.5% |
| Blood Pressure |
0.5% |
|
| Tremor |
11.0% |
| Urinary Tract Infection |
9.0% |
| Renal Failure Acute |
8.0% |
| Syncope |
8.0% |
| Electrocardiogram Qt Prolonged |
7.0% |
| Cholelithiasis |
6.0% |
| Visual Impairment |
6.0% |
| Haemoglobin Decreased |
5.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Hypotension |
4.0% |
| Hypoxia |
4.0% |
| Mental Status Changes |
4.0% |
| Pruritus Generalised |
4.0% |
| Cellulitis |
3.0% |
| Haemorrhagic Stroke |
3.0% |
| Metastatic Neoplasm |
3.0% |
| Orthostatic Hypotension |
3.0% |
| Subdural Haematoma |
3.0% |
| Urticaria |
3.0% |
| Asthma |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.2% |
| Rheumatoid Arthritis |
9.2% |
| Cardiac Disorder |
7.7% |
| Pain |
7.7% |
| Thrombosis Prophylaxis |
4.6% |
| Depression |
3.1% |
| Renal Transplant |
3.1% |
| Drug Use For Unknown Indication |
1.5% |
| Gastritis |
1.5% |
| Hair Growth Abnormal |
1.5% |
| Hypertension |
1.5% |
| Inappropriate Antidiuretic Hormone Secretion |
1.5% |
| Osteoporosis Prophylaxis |
1.5% |
| Pain Prophylaxis |
1.5% |
| Pancreatic Insufficiency |
1.5% |
| Prophylaxis |
1.5% |
| Surgery |
1.5% |
|
| Arthralgia |
5.9% |
| Atrial Fibrillation |
5.9% |
| Bradycardia |
5.9% |
| Deep Vein Thrombosis |
5.9% |
| Depressed Level Of Consciousness |
5.9% |
| Epistaxis |
5.9% |
| Haemoglobin Decreased |
5.9% |
| Hypersensitivity |
5.9% |
| Nasopharyngitis |
5.9% |
| Osteoarthritis |
5.9% |
| Sepsis |
5.9% |
| Streptococcal Sepsis |
5.9% |
| Suicidal Ideation |
5.9% |
| Therapeutic Agent Toxicity |
5.9% |
| Thrombosis |
5.9% |
| Toxicity To Various Agents |
5.9% |
| Vomiting |
5.9% |
|
| Interacting |
| Arrhythmia Prophylaxis |
66.7% |
| Back Pain |
33.3% |
|
| Subdural Haematoma |
80.0% |
| Labelled Drug-drug Interaction Medication Error |
20.0% |
|
